Halozyme Therapeutics, Inc. (BMV:HALO)
1,017.50
+59.50 (6.21%)
At close: May 16, 2025
Market Cap | 133.98B |
Revenue (ttm) | 22.16B |
Net Income (ttm) | 9.92B |
Shares Out | n/a |
EPS (ttm) | 76.83 |
PE Ratio | 13.51 |
Forward PE | 9.33 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 200 |
Average Volume | 1,178 |
Open | 1,017.50 |
Previous Close | 958.00 |
Day's Range | 1,017.50 - 1,017.50 |
52-Week Range | 954.15 - 1,017.50 |
Beta | n/a |
RSI | n/a |
Earnings Date | Aug 5, 2025 |